nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A-kinase anchoring protein 150 controls protein kinase C-mediated phosphorylation and sensitization of TRPV1
|
Jeske, Nathaniel A. |
|
2009 |
146 |
3 |
p. 301-307 7 p. |
artikel |
2 |
A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain
|
Rowbotham, Michael C. |
|
2009 |
146 |
3 |
p. 245-252 8 p. |
artikel |
3 |
A response to McQuay and Moore editorial “Opioids in non-cancer pain – A critical read of Cicero et al.”
|
Cicero, Theodore J. |
|
2009 |
146 |
3 |
p. 325-326 2 p. |
artikel |
4 |
Are we getting anywhere in human pain genetics?
|
Mogil, Jeffrey S. |
|
2009 |
146 |
3 |
p. 231-232 2 p. |
artikel |
5 |
A systematic review of adverse events in placebo groups of anti-migraine clinical trials
|
Amanzio, Martina |
|
2009 |
146 |
3 |
p. 261-269 9 p. |
artikel |
6 |
Author Index to Volume 146 (2009)
|
|
|
2009 |
146 |
3 |
p. 327-330 4 p. |
artikel |
7 |
Baroreceptor reflex is suppressed in rats that develop hyperalgesia behavior after nerve injury
|
Gemes, Geza |
|
2009 |
146 |
3 |
p. 293-300 8 p. |
artikel |
8 |
Contents to Volume 146 (2009)
|
|
|
2009 |
146 |
3 |
p. 336-338 3 p. |
artikel |
9 |
Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo-controlled trial
|
Chappell, Amy S. |
|
2009 |
146 |
3 |
p. 253-260 8 p. |
artikel |
10 |
Editorial list
|
|
|
2009 |
146 |
3 |
p. iii-iv nvt p. |
artikel |
11 |
Endogenous opioids may buffer effects of anger arousal on sensitivity to subsequent pain
|
Burns, John W. |
|
2009 |
146 |
3 |
p. 276-282 7 p. |
artikel |
12 |
Hypnosis for chronic pain management: A new hope
|
Jensen, Mark P. |
|
2009 |
146 |
3 |
p. 235-237 3 p. |
artikel |
13 |
Inhibition of cardiac baroreflex by noxious thermal stimuli: A key role for lateral paragigantocellular serotonergic cells
|
Gau, Rémi |
|
2009 |
146 |
3 |
p. 315-324 10 p. |
artikel |
14 |
Instructions to authors
|
|
|
2009 |
146 |
3 |
p. vi-viii nvt p. |
artikel |
15 |
Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations
|
Dworkin, Robert H. |
|
2009 |
146 |
3 |
p. 238-244 7 p. |
artikel |
16 |
Medical evaluation of children with chronic abdominal pain: Impact of diagnosis, physician practice orientation, and maternal trait anxiety on mothers’ responses to the evaluation
|
Williams, Sara E. |
|
2009 |
146 |
3 |
p. 283-292 10 p. |
artikel |
17 |
Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment
|
Walter, Carmen |
|
2009 |
146 |
3 |
p. 270-275 6 p. |
artikel |
18 |
Nicotinic acetylcholine receptor agonism: Progress in the management of neuropathic pain?
|
Sindrup, Søren H. |
|
2009 |
146 |
3 |
p. 227-228 2 p. |
artikel |
19 |
Perisurgical amitriptyline produces a preventive effect on afferent hypersensitivity following spared nerve injury
|
Arsenault, Andre |
|
2009 |
146 |
3 |
p. 308-314 7 p. |
artikel |
20 |
Response to Cicero et al.
|
McQuay, Henry |
|
2009 |
146 |
3 |
p. 326- 1 p. |
artikel |
21 |
Should we switch from analgesics to the concept of “Pain Modifying Analgesic Drugs (PMADs)” in osteoarthritis and rheumatic chronic pain conditions?
|
Perrot, Serge |
|
2009 |
146 |
3 |
p. 229-230 2 p. |
artikel |
22 |
Subject Index to Volume 146 (2009)
|
|
|
2009 |
146 |
3 |
p. 331-335 5 p. |
artikel |
23 |
The case for publishing ‘negative’ clinical trials
|
Rowbotham, Michael C. |
|
2009 |
146 |
3 |
p. 225-226 2 p. |
artikel |
24 |
The importance of emotional processes in the modulation of pain
|
Rhudy, Jamie L. |
|
2009 |
146 |
3 |
p. 233-234 2 p. |
artikel |